Atlas Trials

Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children

Clinical trial NCT03667053 · COMPLETED

Trial details

NCT number
NCT03667053
Sponsor
Zealand Pharma
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypoglycemia
Start date
2018-09-28
Primary completion
2019-06-28
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.